Anticorps Recombinant de lapin anti-PD-1/CD279
PD-1/CD279 Recombinant Antibody for IHC, FC
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain
Applications
IHC, FC
Conjugaison
Non conjugué
CloneNo.
240724G11
N° de cat : 98068-1-RR
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en IHC | tissu d'amygdalite humain, human ovary cancer tissue il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. |
| Résultats positifs en cytométrie | CMSP humaines, |
Dilution recommandée
| Application | Dilution |
|---|---|
| Immunohistochimie (IHC) | IHC : 1:500-1:2000 |
| This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
98068-1-RR cible PD-1/CD279 dans les applications de IHC, FC et montre une réactivité avec des échantillons Humain
| Réactivité | Humain |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Recombinant |
| Type | Anticorps |
| Immunogène | PD-1/CD279 Protéine recombinante Eg0974 |
| Nom complet | programmed cell death 1 |
| Masse moléculaire calculée | 288 aa, 32 kDa |
| Numéro d’acquisition GenBank | BC074740 |
| Symbole du gène | PD-1 |
| Identification du gène (NCBI) | 5133 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Protein A purfication |
| Tampon de stockage | PBS with 0.09% sodium azide |
| Conditions de stockage | Store at 2 - 8°C. Stable for one year after shipment. |
Informations générales
Programmed cell death 1 (PD-1, also known as CD279) is an immunoinhibitory receptor that belongs to the CD28/CTLA-4 subfamily of the Ig superfamily. It is a 288 amino acid (aa) type I transmembrane protein composed of one Ig superfamily domain, a stalk, a transmembrane domain, and an intracellular domain containing an immunoreceptor tyrosine-based inhibitory motif (ITIM) as well as an immunoreceptor tyrosine-based switch motif (ITSM) (PMID: 18173375). PD-1 is expressed during thymic development and is induced in a variety of hematopoietic cells in the periphery by antigen receptor signaling and cytokines (PMID: 20636820). Engagement of PD-1 by its ligands PD-L1 or PD-L2 transduces a signal that inhibits T-cell proliferation, cytokine production, and cytolytic function (PMID: 19426218). It is critical for the regulation of T cell function during immunity and tolerance. Blockade of PD-1 can overcome immune resistance and also has been shown to have antitumor activity (PMID: 22658127; 23169436). It has been reported that PD-1 is heavily glycosylated and migrates with an apparent molecular mass of 47-55 kDa on SDS-PAGE , which is larger than its predicted mass of 32 kDa (PMID: 8671665; 17640856; 17003438).
Protocole
| Product Specific Protocols | |
|---|---|
| IHC protocol for PD-1/CD279 antibody 98068-1-RR | Download protocol |
| FC protocol for PD-1/CD279 antibody 98068-1-RR | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |









